Understanding ADHD at its Core
Attention Deficit Hyperactivity Disorder (ADHD) is a complex condition that affects millions worldwide. Discover how personalised medicine through pharmacogenomics testing can revolutionise ADHD treatment.
What is Pharmacogenomics?
Unravelling Your Unique DNA Code
Pharmacogenomics analyses how your genes affect your body’s response to medications. By understanding your genetic makeup, we can tailor ADHD treatments to your individual needs.
Pharmacogenomics is at the forefront of a new era in ADHD treatment. The following drugs are targeted for detailed analysis as part of the test. Other drugs can be customised if needed.
Clonidine (Catapres), Guanfacine (Tenex, Intuniv), Atomoxetine (Strattera), Methylphenidate (Ritalin, Concerta), Amphetamine, Bupropion Hydrochloride, Dextroamphetamine, Lisdexamfetamine (Vyvanse and Elvanse).
Benefits of Pharmacogenomics Testing
Personalised Medication Plan
> Target medications that are most effective for you.
> Identify medications to avoid.
> Minimise trial-and-error approaches.
Reduced Side Effects
> Mitigate adverse reactions with precise medication choices.
> Enhance treatment compliance.
Improved Treatment Outcomes
Experience enhanced symptom relief and improved daily functioning. Pharmacogenomics testing empowers you with a treatment plan designed to align with your genetic profile, increasing the likelihood of successful outcomes.
The Future of ADHD Treatment
Advancing Healthcare Through Personalised Solutions
Pharmacogenomics is at the forefront of a new era in ADHD treatment. Embrace a future where medications are tailored to your unique genetic code, maximising effectiveness and minimising potential risks.
How to Get Started
Talk to your Health Care Provider Today
Initiating pharmacogenomics testing for ADHD is a collaborative effort between you and your healthcare provider. Discuss the benefits and explore personalised solutions for a brighter, more focused future.